Galbraith Kenneth is Chair & CEO of Zymeworks Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jan 24 | Zymeworks | Common Stock | Sell | Dispose S | No | No | 11.2156 | 5,706 | 64.00 k | 23,762 |
5 Jan 24 | Zymeworks | Common Stock | Sell | Dispose S | No | No | 10.6522 | 18,198 | 193.85 k | 29,468 |
5 Jan 24 | Zymeworks | Common Stock | Option exercise | Acquire M | No | No | 0 | 47,666 | 0.00 | 47,666 |
5 Jan 24 | Zymeworks | RSU Common Stock | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 200,000 |
5 Jan 24 | Zymeworks | Stock Option Common Stock | Grant | Acquire A | No | No | 10.56 | 300,000 | 3.17 mm | 300,000 |
5 Jan 24 | Zymeworks | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 47,666 | 0.00 | 95,334 |